3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
31
Carcinoma, Renal Cell
20
Carcinoma, Non-Small-Cell Lung
19
Neoplasm Metastasis
11
Carcinoma, Hepatocellular
9
Brain Neoplasms
8
Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Squamous Cell Carcinoma of Head and Neck
5
Pancreatic Neoplasms
5
Lung Neoplasms
5
Carcinoma, Transitional Cell
5
Uveal Melanoma
4
Skin Neoplasms
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Mesothelioma
4
Kidney Neoplasms
4
Glioblastoma
4
Carcinoma, Basal Cell
4
Carcinoma
4
Sarcoma
3
Recurrence
3
Multiple Myeloma
3
Lymphoma
3
Liver Neoplasms
3
Gliosarcoma
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Urogenital Neoplasms
2
Interventions
Specimen Handling
3
Doxorubicin
3
Biopsy
3
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
toripalimab
1
talimogene laherparepvec
1
ribociclib
1
peposertib
1
pembrolizumab
1
pazopanib
1
liposomal doxorubicin
1
futibatinib
1
cabozantinib
1
abemaciclib
1
Temozolomide
1
Surgical Procedures, Operative
1
PM 01183
1
Nivolumab
1
Neoadjuvant Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Everolimus
1
Erlotinib Hydrochloride
1
Docetaxel
1
Angptl4 protein, mouse
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leiomyosarcoma
×
Ipilimumab
×
90 days
×
Clear all
No trials found.